BlackRock’s Tiziana Life Sciences TLSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,656
Closed -$1K 5840
2022
Q3
$1K Hold
1,656
﹤0.01% 5769
2022
Q2
$1K Buy
+1,656
New +$1.42K ﹤0.01% 5816
2022
Q1
Sell
-30,619
Closed -$29K 5904
2021
Q4
$29K Sell
30,619
-520,112
-94% -$689K ﹤0.01% 5507
2021
Q3
$804K Sell
550,731
-9,729
-2% -$18K ﹤0.01% 4616
2021
Q2
$1.31M Buy
+560,460
New +$1.39M ﹤0.01% 4433

Other funds holding TLSA

BlackRock's TLSA Position: Q4 2022 in Review

BlackRock sold out of Tiziana Life Sciences (TLSA) in Q4 2022, closing a stake of 1,656 shares — an estimated $1K sold.

BlackRock first reported a position in TLSA in Q2 2021 and held it in 5 quarters. The position peaked at $1.31M in Q2 2021. 23 funds tracked by Wall St. Rank hold TLSA as of Q4 2022.

  • BlackRock reported no remaining Tiziana Life Sciences position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 1,656 Tiziana Life Sciences shares in Q4 2022, an estimated $1K.
  • BlackRock first reported a position in Tiziana Life Sciences in Q2 2021 and held it in 5 quarters.
  • BlackRock's Tiziana Life Sciences position peaked at $1.31M in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.